Status:
COMPLETED
The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension
Lead Sponsor:
Risk Factor Modification Centre
Collaborating Sponsors:
Ontario Ministry of Agriculture, Food and Rural Affairs
Ontario Ginseng Growers Association
Conditions:
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
To determine the effect of North American ginseng on blood pressure in individuals with hypertension.
Detailed Description
Ginseng lacks proper clinical scrutiny for its effect on blood pressure (BP), in spite of observational evidence linking its intake to hypertension. This should be addressed considering the potential ...
Eligibility Criteria
Inclusion
- aged 18 to 85 years
- hypertension as defined by the use of antihypertensive drugs or a seated systolic blood pressure greater than or equal to 140 mm Hg or a diastolic BP greater than or equal to 90 mm Hg at each of 3 pre-study visits.
Exclusion
- secondary hypertension
- diabetes
- kidney
- liver disease
- unstable angina
- ginseng use for two months prior to or during the study
- any changes in the type or dose of antihypertensive drugs one month prior to or during the study
Key Trial Info
Start Date :
April 1 2001
Trial Type :
INTERVENTIONAL
End Date :
October 1 2003
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00219960
Start Date
April 1 2001
End Date
October 1 2003
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Risk Factor Modification Centre, St. Michael's Hospital
Toronto, Ontario, Canada, M5C 2T2